We are live on ! Find out more
TTOO

T2 Biosystems, Inc

Delisted

TTOO was delisted on the 11th of February, 2025.

34 hedge funds and large institutions have $59.8M invested in T2 Biosystems, Inc in 2017 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 3434 (0)

0% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 13

14% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 7

33% less funds holding in top 10

Funds holding in top 10: 32 (-1)

44% less capital invested

Capital invested by funds: $107M → $59.8M (-$47.2M)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $4K

Holders
34
Holders Change
Holders Change %
0%
% of All Funds
0.85%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
13
Increased
6
Reduced
7
Closed
13
Calls
Puts
$4K
Net Calls
-$4K
Net Calls Change
+$51K

TTOO Hedge Fund Activity: Q2 2017 in Review

34 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in T2 Biosystems, Inc (TTOO) for Q2 2017, worth a combined $59.8M — down 44% from $107M a quarter earlier.

Fund positioning in TTOO was balanced in Q2 2017: 13 funds opened new positions, 13 closed out, 6 added to existing stakes and 7 trimmed.

The largest buyer was Fuller & Thaler Asset Management, opening a new position worth an estimated $2.14M. The largest seller was Wellington Management Group, exiting entirely with an estimated $6.66M sold.

  • 34 institutional investors held T2 Biosystems, Inc (TTOO) as of Q2 2017, unchanged from Q1 2017.
  • Funds reported $59.8M of T2 Biosystems, Inc stock for Q2 2017, down 44% quarter-over-quarter.
  • 13 funds opened new T2 Biosystems, Inc positions in Q2 2017 and 13 closed out, a net change of 0 holders.
  • The largest T2 Biosystems, Inc buyer in Q2 2017 was Fuller & Thaler Asset Management, an estimated $2.14M added.
  • The largest T2 Biosystems, Inc seller in Q2 2017 was Wellington Management Group, an estimated $6.66M sold.

Based on aggregated 13F filings for Q2 2017.